Irish Jian 4
4 · Metagenomi Therapeutics, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Metagenomi (MGX) CEO Jian Irish Sells 1,607 Shares, Gifts 228,462
What Happened
Jian Irish, CEO of Metagenomi Therapeutics (MGX), disposed of shares in two transactions reported on Form 4. On 2025-12-05 she transferred (gifted) 228,462 shares for no consideration (114,231 shares to each of two irrevocable trusts). On 2026-03-05 she disposed of 1,607 shares in an open-market sale at $1.60 per share for proceeds of $2,571. The March sale was reported as an automatic sale to satisfy tax withholding and is not presented as a voluntary trade.
Key Details
- Transactions:
- 2025-12-05 — Gift: 228,462 shares @ $0.00 (to Bruce Irish 2023 Irrevocable Trust FBO Jian Irish and Jian Irish 2023 Irrevocable Trust)
- 2026-03-05 — Sale: 1,607 shares @ $1.60 = $2,571 (reported as automatic tax-withholding sale)
- Footnotes of note:
- F1: Gift split into two trusts (114,231 shares each) for no consideration.
- F2: The March sale was automatic to satisfy tax withholding upon RSU vesting (not a volitional trade).
- F3/F4: Reporting person disclaims beneficial ownership of shares held in the two trusts except to the extent of any pecuniary interest.
- Shares owned after the transactions: Not specified in this Form 4.
- Filing timeliness: Form filed 2026-03-09. The March 5 sale appears to be filed within the two-business-day window; the Dec. 5 gift was reported late (well beyond the two-business-day requirement).
Context
Gifts to trusts are estate/planning moves and don’t necessarily signal management sentiment about the stock. Sales described as tax-withholding (automatic dispositions tied to RSU vesting) are routine and typically not considered an intentional market-timing action. Retail investors should treat the small, automatic sale as administrative and the gift as a transfer, and not infer a definitive view on company prospects from these items alone.
Insider Transaction Report
- Gift
Common Stock
[F1]2025-12-05−228,462→ 335,377 total - Sale
Common Stock
[F2]2026-03-05$1.60/sh−1,607$2,571→ 333,770 total
- 292,714(indirect: By Trust)
Common Stock
[F1][F3] - 292,713(indirect: By Trust)
Common Stock
[F1][F4]
Footnotes (4)
- [F1]On December 5, 2025, the Reporting Person transferred 114,231 and 114,231 shares of Issuer common stock to the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish and Jian Irish 2023 Irrevocable Trust, respectively, for no consideration.
- [F2]These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.
- [F3]Shares held by the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Shares held by the Jian Irish 2023 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.